March 21, 2021
File this one under the "hiding in plain sight" category. When you are worth more than most first world countries, you can pretty much do anything you want without consequence. Like, getting a fast-tracked approval from the United States for a Patent on a COVID-19 Test in the midst of a Global Pandemic. Thats right, none other than Richard A. Rothschild was granted US Patent #20200279585A1, as both the applicant and the inventor. What a coincidence!
Never mind that this patent application has a Priority Claim that dates back to 2015!! In US Patent Law, a Priority claim is essentially an "effective date" that would be used in any future infringement claims. So ask yourself, why would the Rothschilds back-date this Patent to 2015 if this virus "suddenly" appeared, "accidentally" in late 2019?
See for yourself. Remember, there are no coincidences.
📂 DOWNLOAD ENTIRE US PATENT FILE BELOW 🗂
ABSTRACT:
"A method is provided for acquiring and transmitting biometric data (e.g., vital signs) of a user, where the data is analyzed to determine whether the user is suffering from a viral infection, such as COVID-19. The method includes using a pulse oximeter to acquire at least pulse and blood oxygen saturation percentage, which is transmitted wirelessly to a smartphone. To ensure that the data is accurate, an accelerometer within the smartphone is used to measure movement of the smartphone and/or the user. Once accurate data is acquired, it is uploaded to the cloud (or host), where the data is used (alone or together with other vital signs) to determine whether the user is suffering from (or likely to suffer from) a viral infection, such as COVID-19. Depending on the specific requirements, the data, changes thereto, and/or the determination can be used to alert medical staff and take corresponding actions."